p300, also known as KAT3B, is a histone acetyltransferase. One of the primary functions of p300 is its role in epigenetic regulation. By acetylating histones, p300 alters the structure of chromatin, promoting transcriptional activation and accessibility of genes. This process allows the cells to respond dynamically to external cues and ensure appropriate gene expression during development, tissue homeostasis, and cellular response to stress and environmental changes. Dysregulation of p300 activity has been implicated in various diseases, including cancer, neurodegenerative disorders, and cardiovascular diseases, making it an attractive target for therapeutic interventions. AkrivisBio’s p300 Inhibitor Screening Assay is a simple method of assessing potential p300 inhibitors in a rapid and high-throughput adaptable assay.
